An Arizona pain practice, trading as the Arizona Pain Stem Cell Institute, offering bone marrow, amniotic and platelet injections across several Phoenix-area offices.
This practice presents itself online as the Arizona Pain Stem Cell Institute, with offices listed in Scottsdale, Glendale, Gilbert, Phoenix and Chandler. It treats patients as outpatients and also runs what it describes as industry-subsidised research studies, which it states are not United States Food and Drug Administration clinical trials. That distinction matters: a study that is not an approved trial does not carry the same oversight, so ask what enrolling would mean for you.
Three injection treatments are described. Bone marrow derived stem cell injections use marrow taken from the patient's own bone. AmnioGenic Flow Therapy uses a product derived from amniotic tissue, offered for low back and limb pain. Platelet-rich plasma is prepared by concentrating platelets from the patient's own blood and is offered for several joints. Procedures are described as outpatient and performed by board-certified pain management physicians, though no individual doctor is named on the page.
The wider practice also offers chiropractic treatment, physical rehabilitation, spinal decompression, acupuncture and TENS units, which deliver a mild electrical current through the skin for pain. The page reviewed carries a last-modified date of March 2021, so some information may be out of date and worth confirming by telephone.
Two of the three sources come from the patient; the amniotic product is donor derived.
The site refers to board-certified pain management physicians but names none of them on the page reviewed.
The practice lists offices in Scottsdale, Glendale, Gilbert, Phoenix and Chandler, Arizona, with a central telephone number of (602) 507-6550. Street addresses, opening hours, the year the practice was founded, the languages spoken and any provision for overseas patients are not stated. The page was last updated in March 2021.
No prices are published. The site states that industry-subsidised research studies reduce typical patient fees by roughly 40 per cent; that figure is published by the practice itself and has not been independently verified, and no base price is given for comparison. Ask for the full cost in writing.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.